The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: A longitudinal study by Olson, Karin et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Medical Research 
Methodology
Open Access Research article
The changing causal foundations of cancer-related symptom 
clustering during the final month of palliative care: A longitudinal 
study
Karin Olson*1, Leslie Hayduk2, Marilyn Cree1, Ying Cui3, Hue Quan4, 
John Hanson5, Peter Lawlor6,7 and Florian Strasser8,9
Address: 1Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada, 2Sociology Department, University of Alberta, Edmonton, 
Alberta, Canada, 3Faculty of Education, University of Alberta, Edmonton, Alberta, Canada, 4Capital Health Regional Palliative Care Program, 
Edmonton, Alberta, Canada, 5Cross Cancer Institute, Edmonton, Alberta, Canada, 6Our Lady's Hospice, Harold's Cross, Dublin, Ireland, 7Division 
of Palliative Care Medicine, Dept of Oncology, University of Alberta, Edmonton, Alberta, Canada, 8Oncological Palliative Medicine, Section 
Oncology, Dept Internal Medicine, Cantonal Hospital, St. Gallen, Switzerland and 9Palliative Care Center, Dept Internal Medicine, Cantonal 
Hospital, St. Gallen, Switzerland
Email: Karin Olson* - karin.olson@ualberta.ca; Leslie Hayduk - lhayduk@ualberta.ca; Marilyn Cree - mcree@ualberta.ca; 
Ying Cui - yc@ualberta.ca; Hue Quan - hquan@cha.ab.ca; John Hanson - johnqhanson@yahoo.com; Peter Lawlor - PLawlor@olh.ie; 
Florian Strasser - fstrasser@bluewin.ch
* Corresponding author    
Abstract
Background: Symptoms tend to occur in what have been called symptom clusters. Early symptom
cluster research was imprecise regarding the causal foundations of the coordinations between
specific symptoms, and was silent on whether the relationships between symptoms remained stable
over time. This study develops a causal model of the relationships between symptoms in cancer
palliative care patients as they approach death, and investigates the changing associations among
the symptoms and between those symptoms and well-being.
Methods:  Complete symptom assessment scores were obtained for 82 individuals from an
existing palliative care database. The data included assessments of pain, anxiety, nausea, shortness
of breath, drowsiness, loss of appetite, tiredness, depression and well-being, all collected using the
Edmonton Symptom Assessment System (ESAS). Relationships between the symptoms and well-
being were investigated using a structural equation model.
Results: The model fit acceptably and explained between 26% and 83% of the variation in appetite,
tiredness, depression, and well-being. Drowsiness displayed consistent effects on appetite,
tiredness and well-being. In contrast, anxiety's effect on well-being shifted importantly, with a direct
effect and an indirect effect through tiredness at one month, being replaced by an effect working
exclusively through depression at one week.
Conclusion: Some of the causal forces explaining the variations in, and relationships among,
palliative care patients' symptoms changed over the final month of life. This illustrates how
investigating the causal foundations of symptom correlation or clustering can provide more detailed
understandings that may contribute to improved control of patient comfort, quality of life, and
quality of death.
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Background
Symptom clustering
Symptoms seldom occur in isolation, and the coordina-
tion between symptoms has led to recent attempts to
locate symptom clusters[1,2]. Developing strategies for
assessing, investigating, and treating coordinated symp-
toms is an important clinical objective because it permits
prioritization of symptom assessment and treatment.
Responding to symptoms in isolation may lead to inap-
propriate treatment if the symptoms are interconnected
by unknown underlying causal structures. Understanding
the causes coordinating symptoms facilitates intervention
by permitting the targeting of causally up-stream features
so that any amelioration spreads to all the causally down-
stream symptoms, thereby minimizing the number of
required interventions.
Most symptom cluster research has focused on symptoms
that occur in the context of active treatment [3-7] but a few
studies have considered symptoms in individuals prior to
treatment [7], or in those no longer receiving curative
treatments [8,9]. Occasionally there are identifiable phys-
iological foundations for symptom clusters [8] but more
commonly, the co-occurrence of symptoms [4,6] and cor-
relation between symptoms [5,9,10] is used to statistically
create clusters. Factor analysis and principal component
analysis [5,7] attempt to locate sets of highly inter-corre-
lated symptoms. Unfortunately, researchers frequently
fail to realize that a fundamental assumption of these ana-
lytic approaches is that there is a statistically-postulated
common cause for each factor or component of clustered
symptoms, and that no symptom within a cluster is per-
mitted to causally influence any other symptom in that
cluster. It seems unlikely, for example, that many readers
recognized that Chow et al's [7] Component-1, which
includes sense of well-being, pain, fatigue, and drowsi-
ness, implicitly statistically forbids pain, fatigue and
drowsiness from being causes of well-being, and statisti-
cally requires that these four symptoms became correlated
primarily through their dependence on a single common
cause.
Since one objective of studying symptom coordination is
to locate effective treatments, it is critical that researchers
do not inadvertently combine statistical analyses of symp-
toms in ways that are causally inconsistent. For example it
is causally inconsistent to use factor analysis to claim that
a certain set of symptoms are highly correlated and there-
fore form a cluster that should be treated as a unit, and
then use other statistical methods such as ANOVA and
regression to claim differences in the causes of symptoms
within the cluster [5].
The appropriate research response seems clear – if we wish
to investigate causal connections between symptoms, we
need an analytic approach that does not statistically for-
bid the creation of such connections. This conclusion is
consistent with the call by Barsevick et al [9] for use of
path and structural equation models in symptom cluster
research. Both these styles of analysis seek causal structur-
ing and control for potentially confounded variables, but
structural equation modeling is superior because it per-
mits adjustment for measurement error, provides a test of
the model, and produces diagnostics relevant to model
reassessment. Structural equation modeling is superior to
other analytic approaches such as regression and ANOVA
because it prods the researcher to theorize holistically
about the full set of modeled symptoms.
The initial model that was proposed for this study was
drawn from our clinical observations of patients on an
acute palliative care unit. We thought we could see evi-
dence of connections between symptoms but noticed that
the nature of the symptom connections seemed to change
during the last month of life. We decided to use structural
equation models to gain a more detailed understanding of
the causal foundations of the symptoms reported by
patients. We thought that changes in causal relationships
among the symptoms would underlie the changes in the
connections between symptoms.
Conceptual model
Normally the effects specified in structural equation mod-
els are drawn from published reports of other studies. In
our case, the dearth of relevant causally-oriented research
necessitated that relationships in our model be based on
our clinical observations and experience. The symptoms
included in our model were those that commonly occur in
palliative patients, as measured using the modified
Edmonton Symptom Assessment System (ESAS), an
instrument comprised of eight symptoms and well-being,
all measured using numerical rating scales [11].
Based on clinical experience and symptom pathophysiol-
ogy, we classified the 9 items from the ESAS into two cat-
egories (see Figure 1). Pain, anxiety, nausea, shortness of
breath and drowsiness were selected as exogenous or
background variables. Appetite, tiredness (fatigue),
depression, and well-being were specified as endogenous
or dependent variables. Although the measure of depres-
sion in the ESAS is more akin to a downturn in mood as
opposed to a clinical state as outlined in Diagnostic and
Statistical Manual of Mental Disorders (DSM) IV [12], the
decision to include depression as an endogenous variable
was based on Post's kindling theory [13], the work of
Francoeur [8] with advanced cancer patients, and the
Edmonton Fatigue Framework recently published by our
group [14].BMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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The variances of, and covariances between, the endog-
enous variables were modeled as arising from effects orig-
inating in the exogenous variables, and/or effects of other
endogenous variables. The error term attached to each
endogenous variable encapsulates the net impact of all
unidentified causal factors. The model does not examine
the causal sources of the coordination between the exoge-
nous variables but it examines the effects of the exogenous
variables, and it both permits and statistically adjusts for
covariances between these variables. The locations of the
potential effects specified in the model were driven by our
best clinical assessments but we nonetheless anticipated
that the data might prompt inclusion of a few additional
effects, or speak against some included-effects by provid-
ing insignificant effect estimates.
Methods
Study sample
Following receipt of ethical clearance from the Health
Research Ethics Board at the University of Alberta, uniden-
tified patients who met eligibility criteria were selected
from the symptom control database of the Capital Health
Regional Palliative Care Program (CHRPCP). All patients
were admitted to either the inpatient palliative unit or a
hospice within the CHRPCP from 1995–2000, and had
complete Edmonton Symptom Assessment System
(ESAS) scores on both day seven of the fifth week before
death (1 month) and day seven of the second week (one
week) before death. In addition, all patients had a Mini
Mental Status Exam (MMSE) score of at least 22/30 within
three days of both data collection points, since the MMSE
was routinely completed twice per week at that time. A
Mini Mental Status Exam score of at least 22/30 is rou-
tinely used in our setting to indicate that patients' cogni-
tive abilities enable them to provide valid responses as
they personally complete the ESAS. All patients were
receiving symptom control interventions and other sup-
portive and palliative care treatments, but were not receiv-
ing any anticancer treatments. All data (diagnoses, age,
gender, symptom scores, and well-being scores) were
obtained from the patient database maintained by the
CHRPCP.
Measures
Patients reported their current (at that moment) pain,
tiredness, nausea, depression, anxiety, drowsiness, appe-
tite, shortness of breath and well-being using either the
earlier (1992–1999) 100 millimetre visual analogue, or
the more recent (since 1999) numerical rating scale ver-
sion of the ESAS. Several research groups have shown that
the ESAS is both reliable and valid [15-17]. The low end
of both versions of the ESAS was anchored by the word
"absent" or, in the case of well-being, "best possible",
while the high end of the symptom and well-being scales
The basic symptom model Figure 1
The basic symptom model.BMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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were anchored by "worst possible." Patients using the vis-
ual analogue ESAS placed a mark on a 100 millimeter line
corresponding to the intensity of each of the eight symp-
toms and their well-being. The distance from 0 to the
mark was measured in millimeters and rounded to the
nearest 10 (such as 10, 20, 30). In the numerical rating
version patients circle a number from 0 to 10 (such as 1,
2, 3) that best described the intensity of each symptom
and well-being. The numerical rating scale scores were
multiplied by 10 prior to entry into the CHRPCP database
to provide them a 0 to 100 range comparable to that of the
visual analogue scale. At the time the study data were col-
lected, the ESAS was completed once per day in the hos-
pices and twice per day in the inpatient palliative unit. If
two ratings were provided, the average of these two scores
was used.
Analysis
Covariance matrices were constructed for the measures
obtained on day seven of week five (one month) and day
seven of week two (one week) before death, and were
used as input for Version 8.72 s of the Linear Structural
Relations (LISREL) program [18] to obtain maximum
likelihood estimates of the coefficients in the Figure 1
model. Measurement error variances were established
based on the expected accuracies of measurement. The
measurement error variance was set at 5% for symptoms
we thought were easier for patients to assess, such as appe-
tite, pain, nausea, and shortness of breath. The measure-
ment error variance was set at 10% for symptoms we
thought were more difficult for patients to assess, such as
tiredness, drowsiness, depression, anxiety, and well-
being. The model revisions outlined below were made
based on large modification indices whenever the coeffi-
cients were theoretically plausible and the model
remained stable. Readers unfamiliar with structural equa-
tion modeling might consult Hayduk [19] or Bollen [20]
and those desiring background on measurement error
adjustments in the context of single indicators might see
Hayduk [19,21].
Results
Of the 140 patients who had MMSE scores of 22/30 or
higher, complete sets of scores (all 8 symptoms plus well-
being) were available for 82 individuals. These individu-
als ranged in age from 37 to 93 years with a mean age of
64. Forty-nine (60%) subjects were females. The majority
of patients were diagnosed with one of four cancers: 27%
with gastro-intestinal cancer; 21% with genito-urinary
cancer; 20% with lung cancer; and 12% with breast can-
cer. Means and standard deviations for the symptom
scores at both one month and one week before death are
shown in Table 1.
Notice that there is substantial variability in all the meas-
urements at both time points, and that all symptoms
tended to became more intense and more variable as the
time of death approached.
The covariance matrices used in estimating the models are
provided in Table 2. Table 3 contains the estimates for the
coefficients in the two models, and it is to these that we
now turn.
One month (day 7 of week 5) before death
Our initial modeling attempted to be conservative by per-
mitting all the endogenous variables' error terms to covary
but this resulted in large yet insignificant covariances sug-
gestive of colinearity. We removed the correlations among
the error terms and respecified the model as an all-η
model [19] in order to gain more detailed diagnostic
information. The resulting modification indices suggested
an additional direct effect of appetite on well-being. Since
this was clinically reasonable, this effect was included, as
shown in Figure 1, and resulted in a reasonable fit
between the one-month data and the model's implica-
tions (χ2 = 14.2 with 9 degrees of freedom; p = 0.11).
Although the fit between the one-month data and the Fig-
ure 1 model was now "acceptable" in the sense that χ2 did
not detect significant inconsistencies, this model under-
went one additional revision. Based on the modification
indices, a theoretically reasonable effect of anxiety on
well-being was added and resulted in χ2 = 4.9 with 8
degrees of freedom, p = 0.77. No further changes were
made to this model. The estimates of the effects in this
model are included in Table 3, and the significant effects
are presented in the top of Figure 2.
This model explains over 70% of the variation in each of
two symptoms (tiredness and depression) as well as well-
being (Table 3). The strongest effects in this model were
Table 1: Means and standard deviations of symptom scores one 
month and one week before death
Symptom One Month One Week
Mean (s.d.) Mean (s.d.)
Appetite 46.8 (29.9) 60.3 (32.1)
Tiredness 43.2 (20.0) 58.5 (25.0)
Depression 32.9 (22.7) 38.5 (29.1)
Well-being 42.4 (23.5) 49.0 (23.4)
Pain 37.5 (22.7) 44.0 (26.9)
Anxiety 33.4 (24.0) 38.1 (28.5)
Nausea 18.4 (16.0) 25.7 (24.9)
Shortness of Breath 24.0 (21.1) 31.7 (27.2)
Drowsiness 39.8 (22.5) 55.6 (27.7)
Standard deviations (s.d.) in parentheses; symptoms scored 0 = best 
possible to. 100 = worst possibleBMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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those connecting anxiety to depression (0.68, standard-
ized 0.72) and drowsiness to tiredness (0.84, standard-
ized 0.94). The two significant predictors of depression
(anxiety and tiredness) are the major contributors to the
71% explained variation in depression. Eighty percent of
the variation in tiredness was primarily attributable to
drowsiness, pain, and anxiety. Well-being improved when
appetite improved and when there was decreased anxiety
and drowsiness, which collectively account for about 72%
of the variance in well-being. Fifty-one percent of the var-
iation in appetite was explained, primarily by the signifi-
cant effects from pain, drowsiness, and shortness of
breath.
One week (day 7 of week 2) before death
Despite what would traditionally be viewed as excellent fit
between the data and the original one-week model (χ2 =
5.3 with 9 degrees of freedom; p = 0.80), we reviewed the
Table 2: Indicator Covariance Matrices and Latent Exogenous Variable Correlations
Symptom Appetite Tired-ness Depression Well-being Pain Anxiety Nausea Short of Breath Drowsiness
One Month Before Death (n = 82)
Appetite 895.3
Tiredness 242.4 399.6
Depress. 296.1 188.5 513.6
Well-being 427.5 218.8 320.6 550.1
Pain 370.8 221.8 231.3 255.7 514.4 0.47 0.41 0.40 0.48
Anxiety 336.0 110.6 388.1 390.7 236.9 577.2 0.50 0.14 0.57
Nausea 172.4 97.6 177.7 144.6 153.3 190.3 297.2 0.16 0.40
Short of Breath 8.5 87.5 43.0 70.3 181.2 66.3 54.6 443.5 0.19
Drowsy 353.4 332.4 301.2 321.4 227.3 275.9 143.0 85.0 505.8
One Week Before Death (n = 82)
Appetite 1029.2
Tiredness 318.4 623.3
Depress. 250.5 261.9 848.6
Well-being 426.3 262.9 446.2 549.8
Pain 166.4 310.1 276.5 226.1 715.9 0.40 0.37 0.42 0.43
Anxiety 205.2 241.8 661.9 372.4 280.1 811.5 0.65 0.33 0.49
Nausea 150.7 177.6 423.6 300.1 234.4 423.5 620.8 0.39 0.39
Short of Breath 204.4 164.4 347.7 227.4 288.5 243.8 252.2 739.6 0.32
Drowsy 406.6 522.2 359.0 376.6 295.1 345.6 250.5 226.7 765.1
*Indicator variances on the diagonal, indicator covariances below the diagonal, and correlations of the corresponding latent exogenous variables 
obtained from LISREL's standardized phi matrix in bold above the diagonal. Correlations between any pair of latent indicators can be calculated 
from the lower triangular entries by dividing the covariance between the indicators by the square root of the product of the two relevant variances 
Cov XY Var(X) Var(Y) () /
Table 3: Unstandardized Direct Effects in the Structural Equation Models
To Time Until Death From R2
Appetite Tired Depress Well-Being Pain Anxiety Nausea Shortness of Breath Drowsy
Appetite 1 Month -- -- -- -- 0.60* 0.18 0.01 -0.35* 0.43* 0.51
1 Week -- -- -- -- -0.06 0.01 -0.03 0.14 0.58* 0.26
Tired 1 Month -0.05 -- -- -- 0.25* -0.31* -- -- 0.84* 0.80
1 Week 0.02 -- -- -- 0.17* -0.08 -- -- 0.71* 0.73
Depress 1 Month -- 0.32* -- -- 0.03 0.68* -- -0.09 -- 0.71
1 Week -- 0.07 -- -- -0.06 0.84* -- 0.22* -- 0.83
Well-Being 1 Month 0.21* -- -0.01 -- -- 0.46* -- 0.04 0.28* 0.72
1 Week 0.26* -- 0.42* -- -- -- -- -0.01 0.17* 0.72
*Coefficient is more than 2.0 standard errors from zero (significant at the 0.05 level)
-- Denotes coefficients that were excluded (zero) by model specificationBMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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diagnostics for this model. The largest modification index
suggested an effect from well-being to anxiety, which
might be clinically possible, but the estimate of this effect
was insignificant and statistically unstable, so no revisions
were made to the Figure 1 model for one week before
death.
In agreement with the one-month model, the positive
effects leading from anxiety to depression and from drow-
siness to tiredness remained very strong (Table 3).
Because a one unit increase in anxiety causes nearly a cor-
responding unit increase in depression (0.84, standard-
ized 0.82), anxiety contributes most of the explained
(83%) variation in depression. Drowsiness (primarily)
and pain (slightly) explained nearly three quarters (73%)
of the variation in tiredness. A combination of appetite,
depression, and drowsiness accounted for 72% of the var-
iation in well-being. Drowsiness was the only variable
contributing significantly to the 26% explained variation
in appetite.
Considering the groups together
Of the 17 effects postulated in the baseline model (Figure
1), 12 (or 71%) produced significant effect estimates in
one model or the other – hence the baseline model was
comfortably but not excessively parameterized. And, as we
had anticipated, there were some substantial shifts in the
patterning of effects during the last month of life. If the
effects common to the models are constrained to be equal
(in a multi-group model) this results in significant incon-
sistencies between these models and the data (the differ-
ence-χ2 = 35.9, df = 17, p < 0.01), so there is clear evidence
that at least some of the effects have changed between one
month and one week prior to death.
Only three effects remained strong and stable throughout
the two time periods included in this study. Drowsiness
consistently led to both decreased appetite and increased
tiredness, and anxiety consistently contributed to depres-
sion (Table 3). From these data we cannot tell what the
participants were anxious about (impending death, fam-
ily, financial or estate matters) but it is clear that anxiety
Significant* effect estimates Figure 2
Significant* effect estimates. Top figure: One month before death. Bottom figure: One week before death. Note: *An 
effect coefficient exceeding two standard errors is reported as statistically significant.BMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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was by far the strongest source of depression throughout
the time frame covered by this study.
The one-month model displayed the most frequent, and
the most wide-spread, effects (Figure 2). The one-week
model contained fewer significant effects, and the pattern
of effects changed importantly during the period from one
month to one week before death. Pain, for example, had
a significant effect on both appetite and tiredness at one
month before death, but only had a significant effect on
tiredness by one week before death. The medical control
of pain in these facilities is state of the art, but improve-
ments in pain control over the final weeks of life do not
explain the declining effects of pain. Table 2 indicates that
the overall level of pain tended to increase and become
more variable over this period – so pain's lack of effects is
not due to either the absence of pain or to restrictions on
the range of pain scores.
We were surprised to observe that nausea had no effect on
appetite at either time period, despite considerable varia-
bility in the severity of nausea scores both within and
between time periods (Tables 1 and 3).
Some of the most intriguing shifts that occurred over the
last month of life concerned depression, well-being, and
anxiety. Notice the absence of an effect of depression on
well-being in the one-month model, and the presence of
a significant effect of depression on well-being in the one-
week model. At one week, anxiety still has a strong effect
on depression but its direct effect on well-being is gone.
(The modification indices did not call for this effect and
estimating this effect resulted in an estimate that was far
from significant, and did not importantly change any
other estimates.) Thus there is a subtle but important shift
from anxiety causing both depression and well-being at
one month before death, to anxiety having an effect on
well-being through depression at one week before death.
The correlation between depression and well-being can be
calculated from Table 2 as 0.60, 0.65 (for the one-month
and one-week models respectively), but our model shows
that only the correlation at one week is consistent with an
effect of depression on well-being. A clinician who
noticed the stability in the correlation between depression
and well-being could not be expected to intuit that only
the correlation at one week before death provided signifi-
cant evidence of an effect of depression on well-being.
Here we see a relatively stable correlation between depres-
sion and well-being emerging from a changing causal
foundation. Another way to consider this is to focus on
the effect of anxiety on well-being. At one month before
death the model diagnostics prodded the inclusion of a
direct effect of magnitude 0.46 with no indication of any
indirect effect through depression because the effect of
depression on well-being is nearly non-existent. At one
week the appearance of a substantial effect of depression
on well-being (0.42) results in there being a substantial
indirect effect of anxiety on well-being via depression
(0.84 × 0.42 = 0.35) that is nearly as strong as the direct
effect of anxiety on well-being in the one-month model.
At one month before death, depression is not importantly
implicated in anxiety's effect, but at one week before death
depression has transformed into being a major carrier of
anxiety's effect on well-being. These findings suggest that
addressing depression could effectively control the effects
of anxiety on well-being at one week but not at one
month.
Most of the negative effects in Table 3 are of little interest
since these are likely to be mere sampling fluctuations
around true null effects, but two significant negative
effects deserve comment. The first of these, the negative
effect of shortness of breath on appetite at one month, fits
with our clinical observations that shortness of breath is
exceptionally distressing, even when intensity scores are
relatively low and that many individuals associate the
ability to eat with the ability to fight the disease process.
We suspect that the interference of low intensity shortness
of breath on eating may trigger a fear of not eating enough
and thus a desire to eat more, independent of the usual
mechanisms that control appetite. By one week before
death, despite a continued decline in both shortness of
breath and appetite, we found a shift to a non-significant
positive relationship. We attribute this change to the
growing effect of drowsiness on appetite, and suspect that
at this point in the illness trajectory, patients were simply
too drowsy to want to eat, irrespective of any distress asso-
ciated with shortness of breath (Table 1).
The other significant negative effect is that of anxiety on
tiredness at one month. We suspect that this relationship
is medication-based because medications that reduce anx-
iety tend to increase tiredness, but this would not explain
why the effect would weaken by one week despite
increases in the levels of both anxiety and tiredness (Table
2). It is possible that the differential size of the negative
effect estimates at one month and one week are sampling
fluctuations around a true negative effect that lies between
the two negative estimates, so we are inclined not to
emphasize this particular shift in effects.
Notice the modest and contrasting indirect effects that
anxiety and pain have on depression through tiredness. At
one month before death, the negative effect means anxiety
works through tiredness to slightly decrease (or relieve)
depression (-0.31 × 0.32 = -0.10), while pain's positive
effect works through tiredness to slightly increase depres-
sion (0.25 × 0.32 = 0.08). Tiredness seems to simultane-
ously act as a releaser of anxiety's, and as a propagator of
pain's, impact on depression at one month before death.BMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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Both these effects are disrupted at one week before death
by the erosion of the effect of tiredness on depression.
There has been considerable debate among clinicians
about whether depression is a cause of tiredness in this
population. Our model postulates and provides evidence
consistent with the opposite of this, namely that tiredness
causes depression. The effect from depression to tiredness
was well identified in our models but the modification
indices did not suggest insertion of this effect and the
effect was not significant if inserted in either the one week
or one month model. This suggests that while the man-
agement of depression is an important clinical objective,
it should not be expected to decrease tiredness.
Correlations among the exogenous latent variables
The background correlations among the exogenous latent
variables (Table 2 above the diagonal and depicted in Fig-
ure 1 but omitted from Figure 2 for legibility) contribute
to the connections between the endogenous symptom
variables because correlations among the causes lead to
correlations among their effects. These exogenous variable
correlations are substantial enough to contribute materi-
ally to connections among the endogenous symptoms.
The minor, but possibly non-negligible, changes in these
exogenous correlations between the one-month and one-
week models may shroud additional causal changes that
contribute to changes in the patterns of correlations
among the endogenous symptoms in our model. Our
models acknowledge and statistically adjust for the exog-
enous correlations, and changes in correlations, but they
do not attempt to delineate the specific causal connec-
tions producing the exogenous variables' correlations.
Hence, the variations in the exogenous variables' correla-
tions, though minor, are possibly pointing to additional
currently unexamined causal changes contributing to
changes in symptom correlations.
Notice that even a substantial correlation, or change in
correlation, between a pair of exogenous variables neither
demands nor forbids consistency in the effects these vari-
ables have on the endogenous symptoms in the models.
Locating specific exogenous causal changes would add to,
or supplement, rather than demand revision of, the causal
features that are producing the connections between the
endogenous symptoms in our models.
Discussion
The search for causal forces that provide the coordination
between symptoms is an alternative to the current
approach to the study of symptom clusters. We consider
the correlations between symptoms to be artifacts that are
created through the action of underlying causal effects.
From this perspective, if the relevant causal forces change,
the symptoms display new patterns of correlations. Stud-
ies using factor analysis presume that a stable common-
cause underlies the symptoms in any given factor. We, on
the other hand, remain receptive to the possibility that
different and even changing causal structures underlie the
connections between symptoms. By continuing to exam-
ining the causal networks underpinning a variety of symp-
toms, we hope to eventually target interventions that
effectively address coordinated sets of symptoms. Symp-
toms reflecting a common cause would be most effec-
tively addressed by proper management of that common
cause, and symptoms linked in a causal chain would be
most effectively addressed by proper management of the
symptom heading the causal chain.
Early studies on symptom clusters [1,2] were silent regard-
ing the stability of symptom coordinations, but recently
Chow and colleagues [7] used factor analysis to show that
symptoms loading on various factors changed over time.
They found that sometimes anxiety and depression
loaded by themselves, and at other times anxiety and
depression loaded with well-being, fatigue, or drowsiness,
but they did not model the causal foundations of these
shifts. We found that the effects coordinating some symp-
toms were stable over time, while others were not. Specif-
ically, we found that the effects of anxiety on depression,
of drowsiness on tiredness, and of appetite on well-being
were stable, while the effects of pain on appetite, anxiety
on well-being, and depression on well-being were not sta-
ble. Based on these findings, some may consider that we
identified three clusters: anxiety/depression, drowsiness/
tiredness, and appetite/well-being. These three pairs of
symptoms do not constitute symptom clusters in our
view. Rather, they are simply pairs of symptoms in which
changes in the first symptom consistently lead to changes
in the second symptom at two points in time. We do not
know whether these relationships would hold over a
longer period of time.
This study is the first to provide quantitative evidence of a
stable causal relationship between appetite and well-
being, but this effect is not surprising. A number of
research groups have reported distress associated with loss
of appetite [22-25]. In addition to the physiological ben-
efits of the intake of nutrients, clinicians have noted the
social importance of appetite. Appetite makes it possible
for patients to share meal times with family and friends in
a manner that feels "normal".
A number of authors have shown that anxiety and depres-
sion are common among palliative patients [26-28]. Wil-
son and colleagues reported that 24% of the participants
in their sample of palliative care patients met the criteria
for at least one anxiety or depressive disorder [29]. The
causes of anxiety and depression in this population range
from medical complications to psychological and existen-BMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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tial concerns [30], and anxiety and depression are often
accompanied by the somatic complaints associated with
advanced disease. These complexities make it tempting to
fall back on common sense by viewing anxiety and
depression as merely "somehow similar." A preferable
approach is to tame the complexity by incorporating it
into an appropriately structured model. Our clinical
observation of patients moving into depression pointed
to anxiety as a source of depression, irrespective of the
multiplicity and diversity of additional sources of both
depression and anxiety. Our model's specification mirrors
what we saw at the bedside, regardless of the additional
and even unknown factors that influence both anxiety
and depression among palliative patients, anxiety led to
depression. An insignificant effect estimate could have
spoken against our understanding, but the estimate for
the effect of anxiety on depression was significant at both
one month and one week before death, suggesting effec-
tive management of anxiety would help reduce depres-
sion. Depression's subsequent but changing effect on
well-being suggests that the degree to which anxiety man-
agement will carry over to patients' perceptions of their
well-being depends on the proximity to death, but given
the potential for at least some improvement in well-being,
this seems worthy of future investigation.
Our modeling of drowsiness and tiredness provides an
instance where we can informatively follow a reviewer's
suggestion to clearly differentiate between common sense
and our model's specification. We modeled drowsiness as
a cause of tiredness. From a common sense perspective,
one may think of drowsiness and tiredness as synonyms
for sleepiness, and hence interpret our model as saying
sleepiness causes sleepiness. Drowsiness as measured by
the ESAS was conceptualized as medication or disease-
induced neurological interference which could occur
throughout the day and not only at the transition from
wake to sleeping, Tiredness as measured by the ESAS was
conceptualized as the lack ability to engage in desired
activities, even when fully awake. Patients are regularly
reminded of these important distinctions when we ask
them to complete the ESAS. Thus the effect of drowsiness
on tiredness is more akin to an effect of mind on body,
than to the common-sense understanding of drowsiness
and tiredness as sleepiness.
Limitations and Strengths
This study is limited in that we had too few cases to be
able to differentiate among types of cancer. Since type of
cancer may influence symptom profile (e.g., breathless-
ness may be more common in lung cancer than in pros-
tate cancer), there remains the possibility of finding even
tighter symptom interconnections and simpler causal
models for specific cancer types. The patient's type of can-
cer is not likely to change importantly in the last weeks of
life, so even if we had included cancer diagnoses in our
analysis, it would not have accounted for the changing
patterns of effects observed in our models. In the future,
we hope to investigate models of the symptoms displayed
by different types of cancers via "stacked" or multi-group
structural equation models.
The majority of our data were collected on an acute palli-
ative unit or in hospice units in extended care centers.
Thus the extent to which these findings generalize to other
palliative care settings is unknown but could be addressed
in future studies by collecting comparable data in home
care and other hospice environments.
The two data collection points in this study were fairly
close together. In a future study we plan to examine addi-
tional data collection points spanning a longer time
period. Also, complete data were only available for only
82 of 140 potential participants and the symptoms that
were assessed were limited to those measured by the ESAS.
It is possible that results might differ with use of other
assessment tools, or more cases. Each of the items
included in the ESAS is far more complex and multifac-
eted than can be represented fully by a numerical rating
scale. For example, recent developments in the assessment
of advanced cancer pain suggest that in order to accurately
assess pain, one must consider the mechanism of pain,
the degree to which pain is a function of movement,
related psychological distress, history of alcohol or drug
addiction, and cognitive function [31,32]. The theoretical
needs of research with palliative patients, however, must
be weighed against patient burden. The ideal data collec-
tion strategy for pain and other symptoms may require
more effort than palliative patients can provide.
It is possible, but unlikely, that measurement of symp-
toms beyond those available in the ESAS would have
altered the main findings of this study. New measures of
variables that are causally down-stream from the variables
in our model would by definition be incapable of influ-
encing the variables in our model. New measures of caus-
ally up-stream variables that influence just the exogenous
variables would have only more clearly specified the
sources of the currently-free covariances between these
variables. New variables influencing only specific endog-
enous variables would have replaced some of the mod-
eled error variables and hence increased the proportion of
explained variance in these variables but the current effect
estimates would not change. Our primary concern was
about whether symptoms that were common causes of
two endogenous symptoms or one exogenous and one or
more endogenous symptoms were missing because this
would have rendered the model misspecified. While this
is the most challenging kind of concern, the fact that both
models fit with minimal model revision constitutes evi-BMC Medical Research Methodology 2008, 8:36 http://www.biomedcentral.com/1471-2288/8/36
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dence that no such causal features are required. If such a
symptom had been missed, the models would have failed
to fit and would have provided covariance residuals diag-
nostically indicative of the location of the missed varia-
ble's effects but this did not happen, so this possibility
seems unlikely in light of the available evidence.
Our above comments alluded to the detailed attention
required in setting up an original structural equation
model. This can be seen as a limitation of the method
because it requires substantially greater effort and
thoughtful engagement than is required by more explora-
tory methods. But encouraging thoughtful engagement
with the relevant substantive variables can also be viewed
as a great strength. The model examined in this study was
constructed by several members of the study team over a
period of several months, based on their clinical observa-
tion that as patients approached death, there were chang-
ing patterns in the patients' ESAS symptom profiles. We
wondered about whether the patterns were real and if so,
how the symptoms included in the ESAS were related to
each other and to well-being. Structural equation mode-
ling provided an opportunity to test ideas that came from
our observations and discussions. From a treatment per-
spective, considerable advantage is gained by encouraging
researchers to propose and test specific thoroughly-con-
sidered causal structures rather than stopping with the
identification of correlated symptoms.
The decisions regarding which variables to model as exog-
enous or endogenous, and which specific effects to
included or excluded, were not difficult in our case but we
might have felt differently had our model failed. A
strength of structural equation modeling is that it pro-
vides an opportunity to test ideas. The model may either
fit the data, as it did in our case or not fit the data and be
considered a "failed" model. Some researchers may be
reluctant to expose their ideas to this kind of risk. The
model test and diagnostics cannot detect all model speci-
fication problems [19] but the testing is strong enough
that passed model tests (as in our models) provide some
substantial reassurance unavailable with procedures like
factor analysis and regression.
An additional methodological strength of our study
design was that the data focus on fixed periods before
death. This approach assisted in the identification of
causal structures because the participants at each time
point were more homogenous in their disease process
than are typical palliative populations or participants
recruited at the time of diagnosis or treatment.
Conclusion
Our findings suggest that some of the causes that coordi-
nate symptoms in palliative care patients remain stable
between one month and one week prior to death (specif-
ically the impact of anxiety on depression, drowsiness on
tiredness, and appetite on well-being), while other causes
(specifically the effect of pain on appetite, and of anxiety
on well-being; and the emergence of an effect of depres-
sion on well-being) do not remain stable.
At any point in the palliative treatment trajectory, an inter-
vention that reduces anxiety is likely to decrease depres-
sion, but how this improves the patients well-being
depends on the proximity of death. Our models suggest
that one month before death an intervention reducing
anxiety would directly contribute to improving well-
being, but at one week a reduction in anxiety would work
through reduced depression to produce well-being.
Tailoring interventions to capitalize on operative causal
forces should optimize effectiveness, but we hesitate to
provide specific advice on the basis of a single study.
Instead, we urge further attention to the causal founda-
tions that give rise to the connections between symptoms
in specific disease groups. Identifying group-appropriate
and time-point-appropriate causal foundations of the
connections between symptoms should maximize clinical
effectiveness and improve patient comfort, quality of life,
and quality of death.
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